$2338 | SAVE $412 | Single User
$4675 | SAVE $825 | Site License
$7013 | SAVE $1,237 | Enterprise License

Ulcerative Colitis -Epidemiology Forecast to 2025

Ulcerative Colitis (UC) -Epidemiology Forecast to 2025
[Lowest Price Guaranteed: $2,338]

Published by Delve Insight: 10 Oct 2017 | 139054 | In Stock
Related Topics: Ulcerative Colitis

Introduction

DelveInsight “Ulcerative Colitis (UC) - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Ulcerative Colitis (UC) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Ulcerative Colitis (UC) prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Ulcerative Colitis (UC). The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Scope of the Report

The Report includes the prevalent population and how will it change over the next eight years.

Prevalent or incident cases segmented by age and sex.

Coverage of key Ulcerative Colitis (UC) subpopulations and its prevalent or incident cases

The key differences in epidemiology patterns across the seven market segments

Key Coverage and Benefits

The report will help in developing business strategies by understanding the trends shaping and driving the global Ulcerative Colitis (UC) market.

Identifying prevalent patient populations as well as risk factors in the global Ulcerative Colitis (UC) market will help to improve product design, pricing, and launch plans.

Organize sales and marketing efforts by identifying the best opportunities for Ulcerative Colitis (UC) therapeutics in each of the markets covered.

Table of Contents
for Ulcerative Colitis (UC) -Epidemiology Forecast to 2025

  • 1. Report Introduction

    2. Snapshot of Total Prevalent or Incident cases by 7 MM

    3. Executive Summary

    • Key Findings

    4. Ulcerative Colitis (UC) Overview

    • Ulcerative Colitis (UC) Definition

    • Pathophysiology

    • Symptoms

    5. Etiology

    6. Risk Factors Associated with Ulcerative Colitis (UC)

    7. Disease Burden & Unmet Need in the Market

    8. Epidemiology and Patient Populations

    • Key Findings

    • Key Sources used and Forecast Methodology

    • Prevalent Cases and Incident Cases-2015-2025

    • Prevalent & Incident Cases by Category-2015-2025

    • Age-Specific Prevalent/ Incident Cases of Ulcerative Colitis (UC)

    • Sex-Specific Prevalent/Incident Cases of Ulcerative Colitis (UC)

    • Disease Type Specific Prevalent/Incident Cases of Ulcerative Colitis (UC)

    9. Prevalent & Incident Cases by 7 MM-2015-2025

    • Ulcerative Colitis (UC) Epidemiology of United States-2025

    • Ulcerative Colitis (UC) Epidemiology of United Kingdom-2025

    • Ulcerative Colitis (UC) Epidemiology of Germany-2025

    • Ulcerative Colitis (UC) Epidemiology of France-2025

    • Ulcerative Colitis (UC) Epidemiology of Spain-2025

    • Ulcerative Colitis (UC) Epidemiology of Italy-2025

    • Ulcerative Colitis (UC) Epidemiology of Japan-2025

    10. Key Takeaways

    11. Appendix

    12. Report Methodology

    13. Consulting Services

List Of Tables
in Ulcerative Colitis -Epidemiology Forecast to 2025

Table 1: Clinical subtypes of Indication

Table 2: Risk Factors

Table 3: Prevalence cases (%) Region wise

Table 4: Sources used for forecasting the data

Table 5: Ulcerative Colitis (UC) Global Epidemiology, (2015-2025)

Table 6: Prevalent Cases of Ulcerative Colitis (UC) (Ages =XX Years), US (2015-2025)

Table 7: Prevalent Cases of Ulcerative Colitis (UC) By Sex (Males & Females), US (2015-2025)

Table 8: Prevalent Cases By Ulcerative Colitis (UC) Sub-population, US (2015-2025)

Table 9: Prevalent Cases of Ulcerative Colitis (UC) (Ages =XX Years), United Kingdom (2015-2025)

Table 10: Prevalent Cases of Ulcerative Colitis (UC) By Sex (Males & Females), United Kingdom (2015-2025)

Table 11: Prevalent Cases By Ulcerative Colitis (UC) Sub-population, United Kingdom (2015-2025)

Table 12: Prevalent Cases of Ulcerative Colitis (UC) (Ages =XX Years), Germany (2015-2025)

Table 13: Prevalent Cases of Ulcerative Colitis (UC) By Sex (Males & Females), Germany (2015-2025)

Table 14: Prevalent Cases By Ulcerative Colitis (UC) Sub-population, Germany (2015-2025)

Table 15: Prevalent Cases of Ulcerative Colitis (UC) (Ages =XX Years), France (2015-2025)

Table 16: Prevalent Cases of Ulcerative Colitis (UC) By Sex (Males & Females), France (2015-2025)

Table 17: Prevalent Cases By Ulcerative Colitis (UC) Sub-population, France (2015-2025)

Table 18: Prevalent Cases of Ulcerative Colitis (UC)(Ages =XX Years), Italy (2015-2025)

Table 19: Prevalent Cases of Ulcerative Colitis (UC) By Sex (Males & Females), Italy (2015-2025)

Table 20: Prevalent Cases By Ulcerative Colitis (UC) Sub-population, Italy (2015-2025)

Table 21: Prevalent Cases of Ulcerative Colitis (UC) (Ages =XX Years), Spain (2015-2025)

Table 22: Prevalent Cases of Ulcerative Colitis (UC) By Sex (Males & Females), Spain (2015-2025)

Table 23: Prevalent Cases By Ulcerative Colitis (UC) Sub-population, Spain (2015-2025)

Table 24: Prevalent Cases of Ulcerative Colitis (UC) (Ages =XX Years), Japan (2015-2025)

Table 25: Prevalent Cases of Ulcerative Colitis (UC) By Sex (Males & Females), Japan (2015-2025)

Table 26: Prevalent Cases By Ulcerative Colitis (UC) Sub-population, Japan (2015-2025)

List Of Figures, Charts and Diagrams
in Ulcerative Colitis -Epidemiology Forecast to 2025

Figure 1: Prevalence cases (%) Region wise

Figure 2: Sources used for forecasting the data

Figure 3: Ulcerative Colitis (UC) Global Epidemiology, (2015-2025)

Figure 4: Prevalent Cases of Ulcerative Colitis (UC) (Ages =XX Years), US (2015-2025)

Figure 5: Prevalent Cases of Ulcerative Colitis (UC) By Sex (Males & Females), US (2015-2025)

Figure 6: Prevalent Cases By Ulcerative Colitis (UC) Sub-population, US (2015-2025)

Figure 7: Prevalent Cases of Ulcerative Colitis (UC) (Ages =XX Years), United Kingdom (2015-2025)

Figure 8: Prevalent Cases of Ulcerative Colitis (UC) By Sex (Males & Females), United Kingdom (2015-2025)

Figure 9: Prevalent Cases By Ulcerative Colitis (UC) Sub-population, United Kingdom (2015-2025)

Figure 10: Prevalent Cases of Ulcerative Colitis (UC) (Ages =XX Years), Germany (2015-2025)

Figure 11: Prevalent Cases of Ulcerative Colitis (UC) By Sex (Males & Females), Germany (2015-2025)

Figure 12: Prevalent Cases By Ulcerative Colitis (UC) Sub-population, Germany (2015-2025)

Figure 13: Prevalent Cases of Ulcerative Colitis (UC) (Ages =XX Years), France (2015-2025)

Figure 14: Prevalent Cases of Ulcerative Colitis (UC) By Sex (Males & Females), France (2015-2025)

Figure 15: Prevalent Cases By Ulcerative Colitis (UC) Sub-population, France (2015-2025)

Figure 16: Prevalent Cases of Ulcerative Colitis (UC) (Ages =XX Years), Italy (2015-2025)

Figure 17: Prevalent Cases of Ulcerative Colitis (UC) By Sex (Males & Females), Italy (2015-2025)

Figure 18: Prevalent Cases By Ulcerative Colitis (UC) Sub-population, Italy (2015-2025)

Figure 19: Prevalent Cases of Ulcerative Colitis (UC) (Ages =XX Years), Spain (2015-2025)

Figure 20: Prevalent Cases of Ulcerative Colitis (UC) By Sex (Males & Females), Spain (2015-2025)

Figure 21: Prevalent Cases By Ulcerative Colitis (UC) Sub-population, Spain (2015-2025)

Figure 22: Prevalent Cases of Ulcerative Colitis (UC) (Ages =XX Years), Japan (2015-2025)

Figure 23: Prevalent Cases of Ulcerative Colitis (UC) By Sex (Males & Females), Japan (2015-2025)

Figure 24: Prevalent Cases By Ulcerative Colitis (UC) Sub-population, Japan (2015-2025)

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

139054 | DIEI0348

Number of Pages

40

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Ulcerative Colitis - Pipeline Review, H1 2017
Ulcerative Colitis - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical an...
09 May 2017 by Global Markets Direct USD $1,700 (normally
USD $2,000)
More Info
SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2017
The Global Ulcerative Colitis Partnering Terms and Agreements since 2010 report provides understandi...
01 Apr 2017 by Current Partnering USD $1,271 (normally
USD $1,495)
More Info
SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2017
The Global Ulcerative Colitis Partnering Terms and Agreements since 2010 report provides understandi...
01 Feb 2017 by Current Partnering USD $1,271 (normally
USD $1,495)
More Info
SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,271 (normally
USD $1,495)
More Info
SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,271 (normally
USD $1,495)
More Info
SAVE 15% today! Ulcerative Colitis Global Clinical Trials Review, H2, 2016
Ulcerative Colitis Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report,...
28 Sep 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Ulcerative Colitis: KOL Insight
Are UC biosimilars a real or perceived threat to branded drugs?Ulcerative colitis (UC) treatment is ...
01 Sep 2016 by FirstWord Pharma USD $6,715 (normally
USD $7,900)
More Info
SAVE 15% today! Ulcerative Colitis: Update Bulletin [Feb 2016]
IntroductionGain new KOL insights on the latest events happening in Ulcerative Colitis. Topics cover...
01 Feb 2016 by FirstWord Pharma USD $846 (normally
USD $995)
More Info
SAVE 15% today! Ulcerative Colitis: KOL Insight
Introductionipeline drugs are poised to reshape the way doctors treat ulcerative colitis (UC). But w...
01 Dec 2015 by FirstWord Pharma USD $6,715 (normally
USD $7,900)
More Info
SAVE 15% today! Ulcerative Colitis: KOL Insight
IntroductionThe Ulcerative Colitis (UC) treatment market is already undergoing radical change as new...
03 Dec 2014 by FirstWord Pharma USD $6,715 (normally
USD $7,900)
More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Download Free Report Summary PDF

Ulcerative Colitis (UC) -Epidemiology Forecast to 2025 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...